Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Galena Biopharma Inc    GALE   US3632561086

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/26/2014 08/27/2014 08/28/2014 08/29/2014 09/02/2014 Date
2.34(c) 2.48(c) 2.39(c) 2.36(c) 2.3 Last
3 563 562 5 854 426 1 450 702 1 012 913 1 294 414 Volume
+11.43% +5.98% -3.63% -1.26% -2.54% Change
More quotes
Company
Galena Biopharma, Inc. is a biotechnology company focused on discovering, developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. It currently develops peptide antigenbased off the shelf cancer immunotherapies for... 
Surperformance© rating of Galena Biopharma Inc
Trading Rating : Investor Rating :
More about the company
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | GALE | US3632561086 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 12,4 M
EBIT 2014 -52,2 M
Net income 2014 -48,2 M
Debt 2014 -
Yield 2014 -
Sales 2015 23,6 M
EBIT 2015 -38,8 M
Net income 2015 -39,9 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 22,5x
Capi. / Sales 2015 11,8x
Capitalization 279 M
More Financials
Latest news on GALENA BIOPHARMA INC
4d ago Leading Small-Cap Stars Health Care Stock for August 27 Morning Session is Ga..
6d ago GALENA BIOPHARMA : GALE) Drops 5.17% on August 21
6d ago Arrowhead Research Corp (ARWR) is Top Small-Cap Star for August 26
6d ago GALENA BIOPHARMA : GALE) Jumps 11.43% on August 26
6d ago Leading Health Care Stock for Small-Cap Stars is Arrowhead Research Corp (ARW..
7d ago Leading Small-Cap Stars Health Care Stock for August 26 Morning Session is Ar..
08/22 GALENA BIOPHARMA : Change in Directors or Principal Officers, Other Events, Fina..
08/22 GALENA BIOPHARMA : GALE) Drops 5.17% on August 21
08/21 Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Exe..
08/11 GALENA BIOPHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
08/11 GALENA BIOPHARMA : Results of Operations and Financial Condition, Financial Stat..
08/11 GALENA BIOPHARMA : Reports Second Quarter 2014 Results
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
Galena Biopharma Inc : Income Statement Evolution
More Financials
EPS Revisions
Galena Biopharma Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF